Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Ann Intern Med. 2013 Jun 18;158(12):853–860. doi: 10.7326/0003-4819-158-12-201306180-00002

Table 2.

Base Case Average Lifetime Costs and QALE for men aged 65 and 75

Cost ($) Incremental Cost ($) QALE(y) Incremental QALE % Treated % Died Prostate Cancer
Age 65
WW 24,520 9.02 34% 6.0%
BT 35,374 10,854 8.14 −0.88 100% 8.9%
RP 38,180 13,660 7.95 −1.07 100% 8.9%
AS 39,894 15,374 8.85 −0.17 78% 4.8%
IMRT 48,699 24,179 8.10 −0.92 100% 8.9%
Age 75*
WW 18,302 6.14 23% 2.6%
BT 28,810 10,508 5.56 −0.58 100% 3.9%
AS 30,048 11,746 5.98 −0.16 61% 2.1%
IMRT 42,286 23,984 5.52 −0.62 100% 3.9%

ABBR: WW: watchful waiting; BT: brachytherapy; RP: radical prostatectomy; AS: active surveillance; IMRT: intensity-modulated radiation therapy

*

Radical prostatectomy not modeled in 75 year olds